Inventor · disambiguated record
William R. Moore
Also filed as: MOORE JR WILLIAM R · MOORE WILLIAM · MOORE WILLIAM R · MOORE WILLIAM R JR
19 granted patents·8 pending applications·82 citations·filing 1991–2024
93Inventor score
Files withPROPELLA THERAPEUTICS INC9HONDA MOTOR CO LTD5LOCUS PHARMACEUTICALS INC3MERRELL DOW PHARMA3AXYS PHARM INC2
Top patents by PatentIndex Score
27 records- 0195US11559534B2Abiraterone prodrugsPROPELLA THERAPEUTICS INC·Filed 2020·Granted Jan 24, 2023·4 cites·23 claims
- 0295US10792292B2Abiraterone prodrugsPROPELLA THERAPEUTICS INC·Filed 2020·Granted Oct 6, 2020·10 cites·30 claims
- 0393US11957696B2Abiraterone prodrugsPROPELLA THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·2 cites·21 claims
- 0492US9682485B2Lifter cups with at least one channel and concentric slitsHONDA MOTOR CO LTD·Filed 2015·Granted Jun 20, 2017·10 cites·20 claims
- 0580US2025099489A1Abiraterone prodrugsPROPELLA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0678US12138273B2Abiraterone prodrugsPROPELLA THERAPEUTICS INC·Filed 2023·Granted Nov 12, 2024·0 cites·34 claims
- 0777US2024139212A1Abiraterone prodrugsPROPELLA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0876US7612200B2Inhibitors of protein kinasesLOCUS PHARMACEUTICALS INC·Filed 2005·Granted Nov 3, 2009·3 cites·1 claims
- 0973US5278171AAzadecalin amides and thioamides as inhibitors of cholesterol biosynthesisMERRELL DOW PHARMA·Filed 1991·Granted Jan 11, 1994·12 cites·11 claims
- 1069US6355460B1Metal mediated serine protease inhibitorsAXYS PHARM INC·Filed 1999·Granted Mar 12, 2002·12 cites·9 claims
- 1169US5084461AAzadecalin amides and thioamides as inhibitors of cholesterol biosynthesisMERRELL DOW PHARMA·Filed 1991·Granted Jan 28, 1992·20 cites·9 claims
- 1262US2025186463A1Abiraterone decanoate prodrugs and use in therapyPROPELLA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1361US8870186B2Seal assembly for a casing hangerHOANG CHAU·Filed 2012·Granted Oct 28, 2014·3 cites·12 claims
- 1460US9415433B2Scrap shape retentionMOORE WILLIAM R·Filed 2010·Granted Aug 16, 2016·1 cites·18 claims
- 1560US2025025417A1Oral abiraterone formulationsPROPELLA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1656US2024050447A1Abiraterone prodrugsPROPELLA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1754US10427740B2Split outer side panel jig and systemHONDA MOTOR CO LTD·Filed 2015·Granted Oct 1, 2019·1 cites·8 claims
- 1854US2023196457A1System for managing investment information and expedited tradingSLAY HUNTER·Filed 2021·Application pending·0 cites
- 1950US9409222B2Reducing waste in metal stamping processes and systems thereforMOORE WILLIAM R·Filed 2011·Granted Aug 9, 2016·1 cites·18 claims
- 2047US2008280891A1Anti-cancer agents and uses thereofLOCUS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2145US10322444B2Apparatus, system, and method for manipulation of nested stamped partsHONDA MOTOR CO LTD·Filed 2017·Granted Jun 18, 2019·0 cites·17 claims
- 2243US10406584B2Methods and apparatus to shape a workpieceHONDA MOTOR CO LTD·Filed 2014·Granted Sep 10, 2019·0 cites·18 claims
- 2343US5350758APiperidyl sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesisMERRELL DOW PHARMA·Filed 1992·Granted Sep 27, 1994·2 cites·7 claims
- 2443US2007185098A1Inhibitors of protein kinasesLOCUS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2541US9381662B2Apparatus having scrap-guiding regions positioned on cutting assemblyHONDA MOTOR CO LTD·Filed 2012·Granted Jul 5, 2016·0 cites·7 claims
- 2633US6255091B1Potentiating metal mediated serine protease inhibitors with cobalt or zinc ionsAXYS PHARM INC·Filed 1996·Granted Jul 3, 2001·1 cites·1 claims
- 2725US5489600APiperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesisFiled 1994·Granted Feb 6, 1996·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when William R. Moore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →